100 Difficult Inspector Questions P1

Why did you release this batch despite the deviation?

The deviation was thoroughly investigated. The impact assessment confirmed that product quality was not affected, and QA approved batch release based on documented evidence.

How can you demonstrate that this CAPA is effective?

We completed an effectiveness check and confirmed that the issue has not recurred.

Why was this deviation not detected earlier?

The investigation identified gaps in monitoring. Additional controls have since been implemented.

Why did this issue happen more than once?

The initial CAPA was not fully effective. A deeper root cause investigation was conducted and additional actions were implemented.

How do you know your root cause is correct?

The root cause is supported by documented evidence, investigation findings, and data analysis.

What evidence supports your conclusion?

Our conclusion is supported by batch records, interviews, trend data, and investigation results.

Why did QA approve this decision?

QA reviewed all available evidence and determined that product quality and patient safety were not impacted.

What would happen if this deviation had not been detected?

There could have been a potential risk to product quality. This is why monitoring and controls are important.

How do you know the product was not affected?

We assessed critical quality attributes, process data, and laboratory results before making the decision.

Can you prove that product quality was not impacted?

Yes. We reviewed manufacturing records, testing results, and investigation findings.

Why did you choose this CAPA?

The CAPA directly addresses the identified root cause and reduces recurrence risk.

How do you prioritize CAPA actions?

We prioritize CAPAs based on risk to product quality and patient safety.

What if the CAPA fails again?

We would reopen the investigation and implement additional corrective actions.

How do you ensure employees follow the new procedure?

Through training, supervision, and effectiveness monitoring.

Why was this procedure not followed?

The investigation identified the reason and corrective actions were implemented.

How do you verify procedural compliance?

Through routine supervision, audits, and record review.

How do you know operators understood the training?

Training effectiveness was assessed through observation and performance evaluation.

Why was the training ineffective?

The investigation identified gaps in content or implementation, which were corrected.

What controls prevent human error?

Procedures, training, verification steps, and supervisory oversight.

Can this error happen again?

The implemented CAPA significantly reduces the likelihood of recurrence.

How do you know your process is under control?

Critical parameters, IPC results, and trend data consistently meet acceptance criteria.

What evidence demonstrates process control?

Validated processes, monitoring data, and product quality reviews.

Why do you believe the process is capable?

Historical performance data demonstrate consistent compliance with specifications.

What trend data do you review?

We review deviations, IPC results, complaints, yields, and quality metrics.

What actions do you take when adverse trends are identified?

We investigate the trend and implement corrective actions when necessary.

Why is this trend acceptable?

The trend remains within predefined limits and does not affect product quality.

How do you justify this acceptance limit?

The limit is scientifically justified and supported by validation data.

What data support your acceptance criteria?

Validation studies, development data, and risk assessments.

Why was this batch accepted despite an atypical result?

The investigation concluded that the result did not affect product quality.

How do you justify this quality decision?

The decision was based on documented evidence and scientific evaluation.

Why was this OOS not considered product-impacting?

The investigation identified the assignable cause and confirmed no impact on released product.

What evidence supports batch release?

Batch records, testing results, deviation assessments, and QA review.

Why did you not reject this batch?

The investigation confirmed that all release requirements were met.

How do you defend this decision to a regulator?

We provide documented evidence supporting the decision-making process.

What would you do differently today?

We would apply the lessons learned and improvements implemented after the investigation.

How do you ensure management is aware of quality risks?

Through escalation processes, quality metrics, and management review meetings.

What quality metrics are reviewed by management?

Deviations, CAPAs, complaints, recalls, audit findings, and trend data.

How do you know your quality system is effective?

Performance indicators demonstrate compliance and continual improvement.

Can you show evidence of continual improvement?

Yes. We can provide completed CAPAs, trend analyses, and process improvements.

What is your biggest quality risk today?

We continuously assess risks and implement controls to manage them.

How do you monitor critical risks?

Through risk assessments, monitoring programs, and management review.

Why should an inspector trust your conclusion?

Because our conclusion is based on objective evidence and documented evaluation.

How do you handle disagreements during investigations?

We review evidence collaboratively and document the rationale for decisions.

How do you prevent bias during investigations?

We focus on facts, records, and evidence-based decision making.

What if new information becomes available later?

We would reassess the investigation and update conclusions if necessary.

How do you ensure transparency during investigations?

All findings, decisions, and supporting evidence are documented.

Why do you believe your investigation was adequate?

The scope, evidence review, and root cause analysis were comprehensive.

How do you verify investigation quality?

QA reviews the investigation for completeness and scientific justification.

What is the most important factor in GMP decision making?

Patient safety and product quality.

How do you balance production targets and quality requirements?

Product quality always takes priority over production targets.